罗素的毒蛇毒害:诊断的挑战
Jing-Hua Lin1, Wang-Chou Sung2, Jiunn-Wang Liao3
1Division of Toxicology, China Medical University Hospital, Taichung, Taiwan.
BioMedicine
|October 13, 2025
概括
拉塞尔的蛇毒,虽然在台湾很少见,但可以呈现异常. 及时诊断和正确的抗毒剂施用对于成功从这种有毒蛇咬伤中恢复至关重要.
科学领域:
- 类学 类学 类学 类学
- 毒理学 毒理学 毒理学
- 临床医学 临床医学
背景情况:
- 拉塞尔的蛇毒在台湾并不常见.
- 典型的症状包括凝血病,功能衰竭,血液溶解和毛细血管泄漏综合征.
- 以前的报道仅限于案例研究.
研究的目的:
- 报告一个罕见的Russell的蛇毒病例与非典型的呈现.
- 为了强调根据蛇的分布和临床迹象考虑罗素的蛇咬的重要性.
- 通过及时和适当的抗毒疗法来强调成功的结果.
主要方法:
- 临床病例报告.
- 基于地理分布的蛇的识别.
- 对临床迹象和症状的监测.
- 通过血清和尿液中毒物检测得到确认.
主要成果:
- 一名患者出现了不典型的迹象和症状,表明拉塞尔的毒蛇中毒.
- 患者在服用正确的抗毒剂后成功康复.
- 通过对患者样本的实验室分析证实了毒化.
结论:
- 拉塞尔的毒蛇咬的异常表现可能会发生.
- 准确的诊断和及时的抗毒药对于管理拉塞尔的毒蛇毒害至关重要.
- 毒素检测测量有助于确认毒素的存在.
相关概念视频
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
289
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
289
Prevention of Further Absorption of Poison
1.2K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.2K
Esophageal Varices-II: Clinical Features and Management
368
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
368
Venous Thrombosis IV: Nursing Management
196
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
196
Varicose Veins II: Diagnostic Studies and Interprofessional Care
186
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
186
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K


